Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BYVaccines

Clinical Characteristics of Vaccinated and Unvaccinated Patients Who Died from COVID-19: A Retrospective Comparative Study.

  1. 1Department of Emergency Medicine, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16310, Türkiye.

Abstract

Background: Fatal COVID-19 cases continued to occur after the introduction of vaccination, particularly among older adults and individuals with chronic comorbidities. This study aimed to describe and compare the demographic and clinical characteristics of vaccinated and unvaccinated adults who died from COVID-19. Methods: This single-center retrospective comparative study included 1525 adults who died from RT-PCR-confirmed COVID-19 during hospitalization between January 2021 and June 2022. Patients were classified according to documented prior vaccination status. Demographic characteristics, comorbidities, vaccine dose number, and vaccination regimens were evaluated. Multivariable logistic regression was used to examine associations between demographic and clinical characteristics and prior vaccination status within this fatal-case population. Results: Of 1525 patients, 364 (23.9%) had documented prior vaccination and 1161 (76.1%) were unvaccinated. Patients with prior vaccination were older than unvaccinated patients (median age, 77 vs. 70 years; p < 0.001) and more frequently had at least one comorbidity (84.1% vs. 66.2%; p < 0.001). In multivariable analysis, older age, hypertension, heart failure, COPD/asthma, and malignancy were independently associated with prior vaccination status. Coronary artery disease showed a borderline association (OR, 1.330; 95% CI, 0.997-1.775; p = 0.052). The model showed modest discrimination (AUC = 0.662) and limited explained variance (Nagelkerke R² = 0.089). Conclusions: Among patients who died from COVID-19, those with documented prior vaccination were older and had a greater burden of several comorbidities than unvaccinated decedents. Because this case-only analysis was restricted to fatal cases and lacked surviving comparison groups and population denominators, the observed associations should be interpreted as descriptive characteristics of the study population and not as estimates of mortality risk or vaccine effectiveness. Differences between vaccination groups may also reflect vaccination prioritization and selection processes inherent in conditioning the analysis on death.

Related

  1. COVID-19 Vaccination and the Risk of Migraine Chronification: A Comparative Cohort Study of Vaccinated and Unvaccinated Patients With Episodic Migraine.
    Mostafa Meshref, Hossam Younis, Khabab Abbasher Hussien Mohamed Ahmed +13
    Brain and behaviorPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Cervical cytological abnormalities and human papillomavirus status in HPV-vaccinated and unvaccinated women: a cross-sectional study.
    Hoda Biari, Mina Galeshi, Shahla Yazdani +2
    BMC women's healthPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
  3. Impact of COVID-19 on gastrointestinal disease in vaccinated and unvaccinated individuals: a population-based cohort study in England.
    Marwa Al Arab, Genevieve Cezard, Colin Crooks +17
    BMJ public healthPeer-reviewedCC BYFull textInfectious diseaseEurope PMC
  4. Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people
    H. Mason, M. Zou, E. Eyles +18
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  5. [Clinical characteristics and in-hospital outcomes of patients receiving antithrombotic therapy in a cardiac intensive care unit in sub-Saharan Africa: a retrospective comparative study at the Cardiology Institute of Abidjan].
    Christelle Gbassi, Florent Koffi, Cédric Kee +10
    The Pan African medical journalPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
BibTeX
@article{isler2026clinical,
  title = {{Clinical Characteristics of Vaccinated and Unvaccinated Patients Who Died from COVID-19: A Retrospective Comparative Study.}},
  author = {Yeşim Işler and Halil Kaya and Abdullah Furkan Ortabük and Melih Yüksel and Mehmet Oğuzhan Ay},
  journal = {Vaccines},
  year = {2026},
  month = sep,
  doi = {10.3390/vaccines14100841},
  url = {https://europepmc.org/article/MED/42931370},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Clinical Characteristics of Vaccinated and Unvaccinated Patients Who Died from COVID-19: A Retrospective Comparative Study.
AU  - Yeşim Işler
AU  - Halil Kaya
AU  - Abdullah Furkan Ortabük
AU  - Melih Yüksel
AU  - Mehmet Oğuzhan Ay
PY  - 2026
DA  - 2026/09/24
JO  - Vaccines
DO  - 10.3390/vaccines14100841
UR  - https://europepmc.org/article/MED/42931370
AB  - Background: Fatal COVID-19 cases continued to occur after the introduction of vaccination, particularly among older adults and individuals with chronic comorbidities. This study aimed to describe and compare the demographic and clinical characteristics of vaccinated and unvaccinated adults who died from COVID-19. Methods: This single-center retrospective comparative study included 1525 adults who died from RT-PCR-confirmed COVID-19 during hospitalization between January 2021 and June 2022. Patients were classified according to documented prior vaccination status. Demographic characteristics, comorbidities, vaccine dose number, and vaccination regimens were evaluated. Multivariable logistic regression was used to examine associations between demographic and clinical characteristics and prior vaccination status within this fatal-case population. Results: Of 1525 patients, 364 (23.9%) had documented prior vaccination and 1161 (76.1%) were unvaccinated. Patients with prior vaccination were older than unvaccinated patients (median age, 77 vs. 70 years; p < 0.001) and more frequently had at least one comorbidity (84.1% vs. 66.2%; p < 0.001). In multivariable analysis, older age, hypertension, heart failure, COPD/asthma, and malignancy were independently associated with prior vaccination status. Coronary artery disease showed a borderline association (OR, 1.330; 95% CI, 0.997-1.775; p = 0.052). The model showed modest discrimination (AUC = 0.662) and limited explained variance (Nagelkerke R² = 0.089). Conclusions: Among patients who died from COVID-19, those with documented prior vaccination were older and had a greater burden of several comorbidities than unvaccinated decedents. Because this case-only analysis was restricted to fatal cases and lacked surviving comparison groups and population denominators, the observed associations should be interpreted as descriptive characteristics of the study population and not as estimates of mortality risk or vaccine effectiveness. Differences between vaccination groups may also reflect vaccination prioritization and selection processes inherent in conditioning the analysis on death.
SN  - 2076-393X
ER  -